icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Prospective Validation of the Enhanced Liver Fibrosis (ELF) Test for the Prediction of Disease Progression in Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
 
Stephen A. Harrison,1 Manal F. Abdelmalek,2 Anna Mae Diehl,2 Stephen Caldwell,3 Mitchell L. Shiffman,4 Reem H. Ghalib,5 Eric Lawitz,6 Don C. Rockey,7 Raul E. Aguilar Schall,8 Catherine Jia,8 Bryan J. McColgan,8 Robert P. Myers,8 G. Mani Subramanian,8 John G. McHutchison,8 Andrew J. Muir,2 Vlad Ratziu,9 Nezam H. Afdhal,10 Zachary D. Goodman,11 Jaime Bosch,12 Arun J. Sanyal13
 
1Pinnacle Clinical Research, San Antonio, TX; 2Duke Clinical Research Institute, Durham, NC; 3University of Virginia, Charlottesville; 4Liver Institute of Virginia, Richmond; 5Texas Clinical Research Institute, Arlington, TX; 6Texas Liver Institute, UT Health, San Antonio; 7Medical University of South Carolina, Charleston; 8Gilead Sciences, Inc., Foster City, CA; 9Hopital Universitaire Pitie Salpetriere, Paris, France; 10Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; 11Inova Fairfax Hospital, Falls Church, VA; 12Universitat Hospital Clínic de Barcelona, Spain, and Universitätsspital Bern, Switzerland; 13Virginia Commonwealth University, Richmond, VA

1113171

1113172

1113173

1113174

1113175

1113176

1113177

References
 
1. Rosenberg W, et al. Gastroenterology 2004;127:1704-13; 2. Angulo P, et al. Gastroenterology 2013;145:782-9; 3. Fontana R, et al. Hepatology 2008;47:789-98; 4. Parkes J, et al. Gut 2010;59:1245-51; 5. Bowlus C, et al. EASL 2017, abstr FRI-382; 6. Vesterhus M, et al. Hepatology 2015;62:189-97; 7. Sanyal A, et al. EASL 2017, abstr GS-004.